Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)
China flag China · Delayed Price · Currency is CNY
12.13
+0.18 (1.51%)
Feb 4, 2026, 3:04 PM CST

SHE:002900 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Net Income
-190.7558.6873.6630.21350.9529.32
Depreciation & Amortization
111.07111.07108.68106.5799.1379.95
Other Amortization
5.65.65.353.784.0211.21
Loss (Gain) From Sale of Assets
-0.19-0.192.6113.311.924.37
Asset Writedown & Restructuring Costs
1.311.31-0.822.91-0.69-0.1
Loss (Gain) From Sale of Investments
-17.78-17.78-56.11-59.83-593.220.15
Provision & Write-off of Bad Debts
1.221.22-2.860.591.84.06
Other Operating Activities
349.5327.341.51-2.3816.16.63
Change in Accounts Receivable
-135.48-135.48-6.74-10.0349.6149.09
Change in Inventory
-98.88-98.88-46.80.6226.4931.87
Change in Accounts Payable
76.776.7-51.4247.19-63.69-239.62
Operating Cash Flow
103.4530.6935.69144.64-12.53-4.51
Operating Cash Flow Growth
--14.02%-75.32%---
Capital Expenditures
-235.14-346.21-299.58-89.22-73.95-145.85
Sale of Property, Plant & Equipment
0.190.030.220.2711.610.58
Cash Acquisitions
---15.98---
Divestitures
-----4.05-
Investment in Securities
-35-6.0846.69500-227.73318.74
Other Investing Activities
44.1620.858.128.2115.8927.82
Investing Cash Flow
-225.79-331.41-260.52419.25-278.23201.29
Long-Term Debt Issued
-859.55280431471.6319.51
Total Debt Issued
948.19859.55280431471.6319.51
Long-Term Debt Repaid
--643.77-242.47-274.74-282.46-230
Total Debt Repaid
-813-643.77-242.47-274.74-282.46-230
Net Debt Issued (Repaid)
135.19215.7737.53156.26189.1489.51
Repurchase of Common Stock
-0.22-0.22-1.17---
Common Dividends Paid
-109.57-104.56-41.04-109.34-34.31-95.79
Other Financing Activities
215202.85-10.41-154.04-198.533.73
Financing Cash Flow
240.4313.85-15.08-107.12-43.71-2.56
Net Cash Flow
118.0713.12-239.91456.77-334.48194.23
Free Cash Flow
-131.69-315.52-263.8955.42-86.48-150.36
Free Cash Flow Margin
-15.06%-27.86%-22.23%5.39%-9.14%-11.23%
Free Cash Flow Per Share
-0.42-1.02-0.860.18-0.28-0.46
Cash Income Tax Paid
41.1342.2692.1285.8574.74130.31
Levered Free Cash Flow
-68.42-366.52-243.0383.23-28.2-219.31
Unlevered Free Cash Flow
-51.05-347.16-228.7297.37-19.57-213.48
Change in Working Capital
-156.54-156.54-96.3249.49107.42-160.1
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.